Back to search

A phase I pharmacokinetic (PK) and pharmacodynamic (PD) trial of weekly 17-allylamino-17 demethoxygeldanamycin (17AAG, NSC-704057) in patients with advanced tumors

Data up to Jan 2025

Published2004
Citations4
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) trial of weekly 17-allylamino-17… (2004) – Journal of Clinical Oncology | Metascience Observatory Explorer